Modulation of growth hormone receptor expression and insulin-like growth factor expression
US9988635B2 · kind B2 · utility
0Cited by
11References
12Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 17, 2016 |
| Grant date | Jun 5, 2018 |
| Priority date | — |
| Expiry date | Jun 17, 2036 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10T436/143333
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds, compositions and methods are provided for modulating the expression of growth hormone receptor and/or insulin like growth factor-I (IGF-I). The compositions comprise oligonucleotides, targeted to nucleic acid encoding growth hormone receptor. Methods of using these compounds for modulation of growth hormone receptor expression and for diagnosis and treatment of disease associated with expression of growth hormone receptor and/or insulin-like growth factor-I are provided. Diagnostic methods and kits are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.